Inflammatory bowel disease treatment related agents

PheWeb

IBD_DRUGS

No definition available.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries None

Check pre-conditions, main-only, mode, ICD version None

Check minimum number of events None

Include endpoints

RX_A07EC02

RX_A07EC01

RX_H02AB06

RX_A07EA

RX_L04AX01

RX_L01BB02

RX_L01BA01

49440

IBD_DRUGS

Extra metadata

First used in FinnGen datafreeze DF4

Similar endpoints

↥

List of similar endpoints to Inflammatory bowel disease treatment related agents based on the number of shared cases.

Broader endpoints:

Any prescribed medicine buy

Narrower endpoints:

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	47996	28608	19388
Unadjusted prevalence (%)	15.56	16.49	14.36
Mean age at first event (years)	51.65	49.16	55.32

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	0.03	2.04 [1.83, 2.27]	1.5e-37	4793
15 years	0.01	1.36 [1.23, 1.50]	3.7e-9	2294
5 years	0.00	2.60 [2.37, 2.85]	3.1e-91	1411
1 year	0.00	3.55 [3.07, 4.09]	5.5e-67	375

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: IBD_DRUGS – Inflammatory bowel disease treatment related agents
GWS hits:

Survival analyses between endpoints

↥

Plot

before Inflammatory bowel disease treatment related agents
after Inflammatory bowel disease treatment related agents

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Inflammatory bowel disease treatment related agents

↥